190 related articles for article (PubMed ID: 37711630)
1. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
Zanghì A; Manuti V; Serviddio G; D'Amico E; Avolio C
Front Immunol; 2023; 14():1226130. PubMed ID: 37711630
[TBL] [Abstract][Full Text] [Related]
2. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
[TBL] [Abstract][Full Text] [Related]
4. miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Muñoz-San Martín M; Gómez I; Quiroga-Varela A; Gonzalez-Del Río M; Robles Cedeño R; Álvarez G; Buxó M; Miguela A; Villar LM; Castillo-Villalba J; Casanova B; Quintana E; Ramió-Torrentà L
Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36724195
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
6. Analysis of potential microRNA biomarkers for multiple sclerosis.
Al-Temaimi R; Alshammari N; Alroughani R
Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
[TBL] [Abstract][Full Text] [Related]
7. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
Arisi I; Malimpensa L; Manzini V; Brandi R; Gosetti di Sturmeck T; D'Amelio C; Crisafulli S; Ferrazzano G; Belvisi D; Malerba F; Florio R; Pascale E; Soreq H; Salvetti M; Cattaneo A; D'Onofrio M; Conte A
Front Immunol; 2023; 14():1234869. PubMed ID: 38152407
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
9. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
[No Abstract] [Full Text] [Related]
10. MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.
Chen J; Zhu J; Wang Z; Yao X; Wu X; Liu F; Zheng W; Li Z; Lin A
Med Sci Monit; 2017 May; 23():2565-2583. PubMed ID: 28550707
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal band versus chitinase-3-like protein-1 in CSF of newly diagnosed relapsing remitting multiple sclerosis.
Samaha DY; Zeitoun YA; Fouad NT; Abdel Aziz AA; Saad MA
Egypt J Immunol; 2023 Jan; 30(1):42-48. PubMed ID: 36591957
[TBL] [Abstract][Full Text] [Related]
12. CSF microRNAs discriminate MS activity and share similarity to other neuroinflammatory disorders.
Perdaens O; Dang HA; D'Auria L; van Pesch V
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32033981
[TBL] [Abstract][Full Text] [Related]
13. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients.
Golabi M; Fathi F; Samadi M; Hesamian MS; Eskandari N
Inflammation; 2022 Aug; 45(4):1815-1828. PubMed ID: 35347537
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients.
Vistbakka J; Sumelahti ML; Lehtimäki T; Elovaara I; Hagman S
Acta Neurol Scand; 2018 Aug; 138(2):130-136. PubMed ID: 29527713
[TBL] [Abstract][Full Text] [Related]
16. Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.
Giuliani A; Lattanzi S; Ramini D; Graciotti L; Danni MC; Procopio AD; Silvestrini M; Olivieri F; Sabbatinelli J
Mult Scler Relat Disord; 2021 Sep; 54():103126. PubMed ID: 34243103
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing-remitting multiple sclerosis.
Lee DH; Peschke M; Utz KS; Linker RA
Eur J Neurol; 2019 Mar; 26(3):540-545. PubMed ID: 30362206
[TBL] [Abstract][Full Text] [Related]
18. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B
Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Keller A; Leidinger P; Steinmeyer F; Stähler C; Franke A; Hemmrich-Stanisak G; Kappel A; Wright I; Dörr J; Paul F; Diem R; Tocariu-Krick B; Meder B; Backes C; Meese E; Ruprecht K
Mult Scler; 2014 Mar; 20(3):295-303. PubMed ID: 23836875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
